CLINICAL_TRIALS
trial_result
· 2024-05-21
Clinical Trial Update: Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma [Phase 2]
Summary
A Phase 2 trial evaluating stereotactic radiation therapy with ipilimumab for metastatic melanoma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Liver Metastases, Lung Metastases | Phase 2 | Status: COMPLETED | Results posted: 2024-05-21